Krystal Biotech, Inc.
DE ˙ DB ˙ US5011471027
257,90 € ↓ -1,10 (-0,42%)
2026-06-04
CENA AKCJI
SecurityDE:4KB / Krystal Biotech, Inc.
InstitutionFmr Llc
Latest Disclosed Ownership4,292,881 shares
Ownership 14.94%
Fmr Llc ownership in 4KB / Krystal Biotech, Inc.

2024-11-12 - Fmr Llc has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,292,881 shares of Krystal Biotech, Inc. (DE:4KB). This represents 14.942 percent ownership of the company. In their previous filing dated 2024-02-12 , Fmr Llc had reported owning 3,349,474 shares, indicating an increase of 28.17 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2024-11-12 2024-11-12 13G/A 3,349,474 4,292,881 28.17 14.94 25.84
2024-02-12 2024-02-12 13G/A 2,385,898 3,349,474 40.39 11.87 40.39
2024-02-09 2024-02-09 13G/A 2,613,272 2,385,898 -8.70 8.46 -16.53
2023-05-10 2023-05-10 13G/A 2,108,853 2,613,272 23.92 10.13 23.72
2023-02-09 2023-02-09 13G/A 1,978,289 2,108,853 6.60 8.19 3.95
2022-02-09 2022-02-09 13G/A 1,252,386 1,978,289 57.96 7.88 24.00
2021-02-08 2021-02-08 13G/A 1,148,286 1,252,386 9.07 6.35 -4.22
2020-02-07 2020-02-07 13G/A 1,235,400 1,148,286 -7.05 6.63 -22.51
2019-02-13 2019-02-13 13G/A 1,235,400 8.56
2017-10-10 2017-10-10 13G 1,200,000 12.44

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F KRYSTAL BIOTECH COM 501147102 4,373,987 24,359 0.56 1,129,888 5.36 0.0118
2026-02-17 2025-12-31 13F KRYSTAL BIOTECH COM 501147102 4,349,628 8,181 0.19 1,072,357 39.92 0.0547
2025-11-13 2025-09-30 13F KRYSTAL BIOTECH COM 501147102 4,341,447 6,686 0.15 766,396 28.62 0.0398
2025-08-14 2025-06-30 13F KRYSTAL BIOTECH COM 501147102 4,334,761 13,929 0.32 595,856 -23.51 0.0336
2025-05-12 2025-03-31 13F KRYSTAL BIOTECH COM 501147102 4,320,832 6,818 0.16 779,046 15.27 0.0497
2025-02-13 2024-12-31 13F KRYSTAL BIOTECH COM 501147102 4,314,014 21,133 0.49 675,833 -13.51 0.0403
2024-11-13 2024-09-30 13F KRYSTAL BIOTECH COM 501147102 4,292,881 9,115 0.21 781,433 -0.67 0.0475
2024-08-13 2024-06-30 13F KRYSTAL BIOTECH COM 501147102 4,283,766 39,874 0.94 786,671 4.18 0.0504
2024-05-13 2024-03-31 13F KRYSTAL BIOTECH COM 501147102 4,243,892 1,857,994 77.87 755,116 155.11 0.0507
2024-02-13 2023-12-31 13F KRYSTAL BIOTECH COM 501147102 2,385,898 -243,485 -9.26 295,995 -2.96 0.0227
2023-11-13 2023-09-30 13F KRYSTAL BIOTECH COM 501147102 2,629,383 -52,214 -1.95 305,008 -3.12 0.0264
2023-08-11 2023-06-30 13F KRYSTAL BIOTECH COM 501147102 2,681,597 484,639 22.06 314,819 78.99 0.0264
2023-08-11 2023-03-31 13F/A-1 KRYSTAL BIOTECH COM 501147102 2,196,958 88,105 4.18 175,888 5.28 0.0161
2023-05-11 2023-03-31 13F KRYSTAL BIOTECH COM 501147102 2,196,958 88,105 175,888 0.0032
2023-02-13 2022-12-31 13F KRYSTAL BIOTECH COM 501147102 2,108,853 2,419 0.11 167,063 13.79 0.0166
2022-11-10 2022-09-30 13F KRYSTAL BIOTECH COM 501147102 2,106,434 178 0.01 146,818 6.16 0.0153
2022-08-12 2022-06-30 13F KRYSTAL BIOTECH COM 501147102 2,106,256 -236 -0.01 138,296 -1.33 0.0138
2022-05-13 2022-03-31 13F KRYSTAL BIOTECH COM 501147102 2,106,492 128,203 6.48 140,166 1.29 0.0112
2022-02-14 2021-12-31 13F KRYSTAL BIOTECH COM 501147102 1,978,289 75,884 3.99 138,381 39.32 0.0102
2022-02-14 2021-09-30 13F/A-1 KRYSTAL BIOTECH COM 501147102 1,902,405 134,488 7.61 99,325 -17.38 0.0079
2021-11-15 2021-09-30 13F KRYSTAL BIOTECH COM 501147102 1,902,405 134,488 99,325 0.0079
2021-08-13 2021-06-30 13F KRYSTAL BIOTECH COM 501147102 1,767,917 426,020 31.75 120,218 16.29 0.0094
2021-05-14 2021-03-31 13F KRYSTAL BIOTECH COM 501147102 1,341,897 89,511 7.15 103,380 37.58 0.0088
2021-02-08 2020-12-31 13F KRYSTAL BIOTECH COM 501147102 1,252,386 -76,900 -5.79 75,143 31.31 0.0067
2020-11-13 2020-09-30 13F KRYSTAL BIOTECH COM 501147102 1,329,286 0 0.00 57,226 3.94 0.0058
2020-08-24 2020-06-30 13F/A-1 KRYSTAL BIOTECH COM 501147102 1,329,286 181,000 15.76 55,059 10.89 0.0061
2020-08-13 2020-06-30 13F KRYSTAL BIOTECH COM 501147102 1,329,286 181,000 55,059 1,352.6385
2020-05-14 2020-03-31 13F KRYSTAL BIOTECH COM 501147102 1,148,286 0 0.00 49,652 -21.92 0.0069
2020-02-07 2019-12-31 13F KRYSTAL BIOTECH COM 501147102 1,148,286 0 0.00 63,592 59.48 0.0070
2019-11-13 2019-09-30 13F KRYSTAL BIOTECH COM 501147102 1,148,286 0 0.00 39,874 -13.77 0.0048
2019-08-13 2019-06-30 13F KRYSTAL BIOTECH COM 501147102 1,148,286 -87,114 -7.05 46,241 13.77 0.0054
2019-05-13 2019-03-31 13F KRYSTAL BIOTECH COM 501147102 1,235,400 0 0.00 40,645 58.32 0.0049
2019-02-13 2018-12-31 13F KRYSTAL BIOTECH COM 501147102 1,235,400 300,000 32.07 25,672 56.12 0.0035
2018-11-09 2018-09-30 13F KRYSTAL BIOTECH COM 501147102 935,400 -264,600 -22.05 16,444 -7.85 0.0018
2018-08-10 2018-06-30 13F KRYSTAL BIOTECH COM 501147102 1,200,000 0 0.00 17,844 47.37 0.0021
2018-05-14 2018-03-31 13F KRYSTAL BIOTECH COM 501147102 1,200,000 0 0.00 12,108 -4.09 0.0014
2018-02-12 2017-12-31 13F KRYSTAL BIOTECH COM 501147102 1,200,000 0 0.00 12,624 5.52 0.0015
2017-11-13 2017-09-30 13F KRYSTAL BIOTECH COM 501147102 1,200,000 1,200,000 11,964 0.0014
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.